268 related articles for article (PubMed ID: 18769256)
21. Mitochondrial myopathies.
DiMauro S
Curr Opin Rheumatol; 2006 Nov; 18(6):636-41. PubMed ID: 17053512
[TBL] [Abstract][Full Text] [Related]
22. High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
Lan MY; Fu MH; Liu YF; Huang CC; Chang YY; Liu JS; Peng CH; Chen SS
Clin Genet; 2010 Dec; 78(6):565-9. PubMed ID: 20370797
[TBL] [Abstract][Full Text] [Related]
23. Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female caused by maternal riboflavin deficiency.
Chiong MA; Sim KG; Carpenter K; Rhead W; Ho G; Olsen RK; Christodoulou J
Mol Genet Metab; 2007; 92(1-2):109-14. PubMed ID: 17689999
[TBL] [Abstract][Full Text] [Related]
24. Substrate kinetics in patients with disorders of skeletal muscle metabolism.
Ørngreen MC
Dan Med J; 2016 Jul; 63(7):. PubMed ID: 27399985
[TBL] [Abstract][Full Text] [Related]
25. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
[TBL] [Abstract][Full Text] [Related]
26. Fulminant lipid storage myopathy due to multiple acyl-coenzyme a dehydrogenase deficiency.
Whitaker CH; Felice KJ; Silvers D; Wu Q
Muscle Nerve; 2015 Aug; 52(2):289-93. PubMed ID: 25556768
[TBL] [Abstract][Full Text] [Related]
27. Genetic risk factors associated with lipid-lowering drug-induced myopathies.
Vladutiu GD; Simmons Z; Isackson PJ; Tarnopolsky M; Peltier WL; Barboi AC; Sripathi N; Wortmann RL; Phillips PS
Muscle Nerve; 2006 Aug; 34(2):153-62. PubMed ID: 16671104
[TBL] [Abstract][Full Text] [Related]
28. Disorders of lipid metabolism in skeletal muscle.
Cwik VA
Neurol Clin; 2000 Feb; 18(1):167-84. PubMed ID: 10658173
[TBL] [Abstract][Full Text] [Related]
29. [Carnitine deficiency myopathy: a case of late diagnosis].
Rico Corral MA; de la Vega Vázquez JM; Holgado Silva C; Aznar Martín A; Zamora Madaría E
An Med Interna; 2002 Aug; 19(8):415-8. PubMed ID: 12244790
[TBL] [Abstract][Full Text] [Related]
30. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency.
Turnbull DM; Bartlett K; Stevens DL; Alberti KG; Gibson GJ; Johnson MA; McCulloch AJ; Sherratt HS
N Engl J Med; 1984 Nov; 311(19):1232-6. PubMed ID: 6493275
[No Abstract] [Full Text] [Related]
31. The Multifaceted Cause of Lipid Storage Myopathies, Genetics, and Treatment.
Angelini C
Front Biosci (Schol Ed); 2024 Jun; 16(2):12. PubMed ID: 38939976
[TBL] [Abstract][Full Text] [Related]
32. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
[TBL] [Abstract][Full Text] [Related]
33. Skeletal Muscle Magnetic Resonance Imaging of the Lower Limbs in Late-onset Lipid Storage Myopathy with Electron Transfer Flavoprotein Dehydrogenase Gene Mutations.
Liu XY; Jin M; Wang ZQ; Wang DN; He JJ; Lin MT; Fu HX; Wang N
Chin Med J (Engl); 2016 Jun; 129(12):1425-31. PubMed ID: 27270537
[TBL] [Abstract][Full Text] [Related]
34. Lipid storage myopathies: Current treatments and future directions.
Vasiljevski ER; Summers MA; Little DG; Schindeler A
Prog Lipid Res; 2018 Oct; 72():1-17. PubMed ID: 30099045
[TBL] [Abstract][Full Text] [Related]
35. [Myopathies related to lipid metabolism disorders (review of the literature)].
Aingorn ED; Zhurba LT; Koroleva IA; Timonina OV; Sitnikov VF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1441-4. PubMed ID: 494923
[No Abstract] [Full Text] [Related]
36. A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.
Kaneko K; Kuroda H; Izumi R; Tateyama M; Kato M; Sugimura K; Sakata Y; Ikeda Y; Hirano K; Aoki M
Neuromuscul Disord; 2014 Jul; 24(7):634-41. PubMed ID: 24836204
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial myopathies.
DiMauro S; Bonilla E; Zeviani M; Nakagawa M; DeVivo DC
Ann Neurol; 1985 Jun; 17(6):521-38. PubMed ID: 3927817
[TBL] [Abstract][Full Text] [Related]
38. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.
Wen B; Dai T; Li W; Zhao Y; Liu S; Zhang C; Li H; Wu J; Li D; Yan C
J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):231-6. PubMed ID: 19758981
[TBL] [Abstract][Full Text] [Related]
39. "Lipid storage myopathy" with muscle carnitine deficiency only.
Buscaino GA; Marolda M; Borgia A; Cocchiararo M; Scarafile P
Acta Neurol (Napoli); 1982 Feb; 4(1):1-13. PubMed ID: 7090864
[No Abstract] [Full Text] [Related]
40. Identification of the infant-type R631C mutation in patients with the benign muscular form of CPT2 deficiency.
Musumeci O; Aguennouz M; Comi GP; Rodolico C; Autunno M; Bordoni A; Baratta S; Taroni F; Vita G; Toscano A
Neuromuscul Disord; 2007 Dec; 17(11-12):960-3. PubMed ID: 17651973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
